Russell Investments Group’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-66,699
Closed -$209K 3871
2024
Q4
$209K Sell
66,699
-9,341
-12% -$45.2K ﹤0.01% 2530
2024
Q3
$375K Sell
76,040
-6,833
-8% -$35.3K ﹤0.01% 2355
2024
Q2
$365K Buy
82,873
+55,765
+206% +$261K ﹤0.01% 2311
2024
Q1
$183K Buy
+27,108
New +$206K ﹤0.01% 2460

Other funds holding SLRN

Russell Investments Group's SLRN Position: Q1 2025 in Review

Russell Investments Group sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 66,699 shares — an estimated $209K sold.

Russell Investments Group first reported a position in SLRN in Q1 2024 and held it in 4 quarters. The position peaked at $375K in Q3 2024. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • Russell Investments Group reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • Russell Investments Group sold 66,699 ACELYRIN shares in Q1 2025, an estimated $209K.
  • Russell Investments Group first reported a position in ACELYRIN in Q1 2024 and held it in 4 quarters.
  • Russell Investments Group's ACELYRIN position peaked at $375K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.